13 results
Comparison of oral anticoagulant agents (DOACS + Warfarin)

Reference: ENLS 2017 Pharmacotherapy. Neurocritical Care Journal.

#DOAC #Dosing #Oral
Comparison of oral ... anticoagulant agents (DOACS ... #DOAC #Dosing #Oral ... Comparison #Table #Pharmacology
Oral anticoagulant dosing and bridging for VTE

- Dr. Joseph Shatzel @Clotmaster 

#VTE #DOAC #Bridging #Dosing #Oral
Oral anticoagulant ... dosing and bridging ... Clotmaster #VTE #DOAC ... #Oral #Anticoagulant ... #Loading #DVT #Pharmacology
Oral Anticoagulation - VTE and DVT Bridging

- Amelia Furbish PharmD Student @ https://www.instagram.com/happypillsrx/

#DOAC #Oral #Anticoagulant #VTE
Oral Anticoagulation ... happypillsrx/ #DOAC ... #Oral #Anticoagulant ... DVT #Bridging #Dosing ... #Pharmacology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... direct-acting oral ... for appropriate dosing ... direct-acting oral ... #Cancer #Algorithm
Perioperative Management of DOACs
Problem:
 ✖ Each year approximately 250,000 patients on chronic anticoagulation in North America
Management of DOACs ... direct acting oral ... anticoagulants (DOACs ... clearance (calculated using ... Management #Treatment #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
• Itraconazole oral ... • Posaconazole oral ... • Itraconazole oral ... opportunistic #infections #HIVAIDS ... #pharmacology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
Treatment algorithm ... Suggested treatment algorithm ... bleeding risk during ... DOAC, direct oral ... #DOAC #VTE #Malignancy
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... five effective oral ... If needed or if oral ... antimicrobials #regimens #pharmacology ... #dosing #idsa #
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
IDSA Recommendations ... regress, change to oral ... HerpesSimplex #HSV #IDSA ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Managing Cryptosporidiosis in HIV-AIDS
Preventing Chronic Cryptosporidiosis:
 • Because chronic cryptosporidiosis occurs
IDSA Recommendations ... • Aggressive oral ... Cryptosporidiosis #IDSA ... opportunistic #infections #HIVAIDS ... #pharmacology